SCHEMBL12220455

SCHEMBL12220455

CC(=O)N1C(=O)C(=C(C)C)C(=O)N1c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ MAPT P10636 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ GAA P10253 3/20 0.46
▸ HPGD P15428 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ ABCB11 O95342 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ PKM P14618 1/20 0.36
▸ RECQL P46063 2/20 0.36
▸ MT-CO2 P00403 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ CES1 P23141 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12220454 0.83 KMT2A (0.43) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL12242962 0.79 KMT2A (0.43) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL29489700 0.69 LMNA (0.42) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL6578091 0.65 SMN1; SMN2 (0.64) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL18481365 0.63 ITGA4 (0.51) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL419811 0.63 KMT2A (1.00) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL12220558 0.62 KMT2A (0.49) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL9473296 0.62 GSK3A (0.63) KMT2AALDH1A1MEN1GAAKDM4E
SCHEMBL21694463 0.61 LMNA (0.61) KMT2AALDH1A1MAPTMEN1GAA
SCHEMBL11066138 0.60 KDM4E (0.38) KMT2AALDH1A1MEN1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039532-B2 Heterocyclic compound, ultraviolet absorbent and composition containing the same FUJIFILM CORPORATION (JP) 2011-10-18 — — US disclosed
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME FUJIFILM CORPORATION (JP) 2010-08-19 — — US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 — — US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME F12, F2, CYP24A1 KMT2A 4498/4885ALDH1A1 1492/4885MAPT 4121/4885
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND SQOR, NQO1, PBRM1 KMT2A 1603/4885ALDH1A1 739/4885MAPT 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback